Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma

Published:2017-12-18 Issue:9 Volume:59 Page:2085-2095
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Arima Hiroshi¹,Fujimoto Masakazu²,Nishikori Momoko¹,Kitano Toshiyuki¹,Kishimoto Wataru¹,Hishizawa Masakatsu¹,Kondo Tadakazu¹,Yamashita Kouhei¹,Hirata Masahiro²,Haga Hironori²,Takaori-Kondo Akifumi¹

Affiliation:

1. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;

2. Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Funder

Japan Society for the Promotion of Science

Scientific Research

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1410884

Reference41 articles.

1. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme

2. Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)

3. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas

4. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells

5. Mechanisms of chromosomal translocations in B cell lymphomas

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity;Advances in Immunology;2024

2. TiSA: TimeSeriesAnalysis—a pipeline for the analysis of longitudinal transcriptomics data;NAR Genomics and Bioinformatics;2023-01-10

3. AID is a poor prognostic marker of high‐grade B‐cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements;Pathology International;2021-11-02

4. Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B;ACS Pharmacology & Translational Science;2021-07-19

5. Association of AID and MUM1 by Immunohistochemistry in Diffuse Large B-Cell Lymphoma;The Indonesian Biomedical Journal;2021-03-01